SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-20-000070
Filing Date
2020-11-02
Accepted
2020-11-02 16:11:38
Documents
16
Period of Report
2020-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20201102.htm   iXBRL 8-K 37309
2 EXHIBIT 99.1 a3q20financialpr.htm EX-99.1 553844
8 GRAPHIC jazzpharmalogo21.jpg GRAPHIC 588601
  Complete submission text file 0001232524-20-000070.txt   1581288

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20201102.xsd EX-101.SCH 2429
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20201102_cal.xml EX-101.CAL 714
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20201102_def.xml EX-101.DEF 1647
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20201102_lab.xml EX-101.LAB 26105
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20201102_pre.xml EX-101.PRE 13678
9 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20201102_htm.xml XML 11680
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 201280584
SIC: 2834 Pharmaceutical Preparations